Natural health product · NPN 80100347
DILAZE
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed May 17, 2020.
- Natural Product Number (NPN)
- 80100347
- Licence holder
- Pharmaline Inc.Mississauga, Ontario, Canada
- Dosage form
- Tablet
- Route
- Oral
- Licensing route
- CompendialThe company attested that the product meets a Health Canada monograph.
- First licensed
- May 17, 2020
Also sold as
Other product names on the same licence.
- LACTASE 200
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| beta-galactosidase | 200 mg | Aspergillus flavus var. oryzae - Whole |
| beta-galactosidase | 2,000 fcc acid lactase units | Aspergillus flavus var. oryzae - Whole |
| beta-galactosidase | 200 mg | Lactase |
| beta-galactosidase | 2,000 fcc acid lactase units | Lactase |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Digestive enzyme. Digestive enzyme/lactase to assist in the digestion of foods containing lactose (e.g. dairy foods, milk). Helps prevent symptoms of lactose intolerance (including gas, bloating, cramping and diarrhea).
Non-medicinal ingredients
Dicalcium phosphate dihydrate; Magnesium stearate; Microcrystalline cellulose; Croscarmellose sodium; PVP